Chinese english Germany Japanese Korea

(1R,2R,3R)-(4S)-AMino-1,2,3-trihydroxy-(5R)-iodocyclopentane 3,4-CarbaMate 1,2-Cyclohexyl Ketal

(1R,2R,3R)-(4S)-AMino-1,2,3-trihydroxy-(5R)-iodocyclopentane 3,4-CarbaMate 1,2-Cyclohexyl Ketal Struktur
CAS-Nr.
Englisch Name:
(1R,2R,3R)-(4S)-AMino-1,2,3-trihydroxy-(5R)-iodocyclopentane 3,4-CarbaMate 1,2-Cyclohexyl Ketal
Synonyma:
(1R,2R,3R)-(4S)-AMino-1,2,3-trihydroxy-(5R)-iodocyclopentane 3,4-CarbaMate 1,2-Cyclohexyl Ketal;(1R,2R,3R,4S,5R)-Hexahydro-7'-iodo-spiro[cyclohexane-1,2'-[5H-1,3]dioxolo[3,4]cyclopent[1,2-d]oxazol]-5'-one
CBNumber:
CB32542860
Summenformel:
C12H16INO4
Molgewicht:
365.16421
MOL-Datei:
Mol file
Request For Quotation

(1R,2R,3R)-(4S)-AMino-1,2,3-trihydroxy-(5R)-iodocyclopentane 3,4-CarbaMate 1,2-Cyclohexyl Ketal Eigenschaften

Löslichkeit
Chloroform
Aggregatzustand
Solid
Farbe
White

Sicherheit

(1R,2R,3R)-(4S)-AMino-1,2,3-trihydroxy-(5R)-iodocyclopentane 3,4-CarbaMate 1,2-Cyclohexyl Ketal Chemische Eigenschaften,Einsatz,Produktion Methoden

Chemische Eigenschaften

White Solid

Verwenden

Mannostatin intermediate.

(1R,2R,3R)-(4S)-AMino-1,2,3-trihydroxy-(5R)-iodocyclopentane 3,4-CarbaMate 1,2-Cyclohexyl Ketal Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

(1R,2R,3R)-(4S)-AMino-1,2,3-trihydroxy-(5R)-iodocyclopentane 3,4-CarbaMate 1,2-Cyclohexyl Ketal Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 6)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Chemsky（shanghai）International Co.,Ltd. 021-50135380
shchemsky@sina.com China 32321 50
S.Z. PhyStandard Bio-Tech. Co., Ltd. 0755-83725681-603
China 4496 50
Santa Cruz Biotechnology Inc 021-60936350
scbt@scbt.com China 6594 58
  • (1R,2R,3R)-(4S)-AMino-1,2,3-trihydroxy-(5R)-iodocyclopentane 3,4-CarbaMate 1,2-Cyclohexyl Ketal
  • (1R,2R,3R,4S,5R)-Hexahydro-7'-iodo-spiro[cyclohexane-1,2'-[5H-1,3]dioxolo[3,4]cyclopent[1,2-d]oxazol]-5'-one
  • C12H16INO4
  • Chiral reagents
  • Inhibitors
  • Intermediates
Copyright 2019 © ChemicalBook. All rights reserved